[Systemic chemotherapy in metastatic colorectal adenocarcinomas].
Bécouarn
Y
Y
Fondation Bergonié, Bordeaux.
Brunet
R
R
Ravaud
A
A
Bussières
E
E
Lagarde
P
P
D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D016685:Mitomycin / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012673:Semustine / Q000627:therapeutic use*
D016898:Interferon-alpha; D009607:Nitrosourea Compounds; D011743:Pyrimidines; D012673:Semustine; D016685:Mitomycin; D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate
Chimiothérapie systémique des adénocarcinomes colorectaux métastatiques.